Examining the public health risks of carcinogens in consumer products :  hearing before the Subcommittee on Economic and Consumer Policy of the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, March 12, 2019. 

 - 1 online resource (iii, 32 pages) :  illustration 
<br/><br/> "Serial no. 116-08."  CRDP Program record. 
<br/><br/>Includes bibliographical references. 
<br/><br/><label>Subjects--Corporate Names: </label><br/>United States. Food and Drug Administration --Rules and practice.<br/>Johnson & Johnson.
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cosmetics--Health aspects--United States.<br/>Talc--Carcinogenicity.<br/>Cosmetics industry--Government policy--United States.<br/>Consumer protection--United States.<br/>Cancer--Prevention.--United States<br/>Asbestos--Health aspects--United States.<br/>Ovaries--Cancer--Etiology.
<br/><br/><label>Index Terms--Genre/Form: </label><br/>Legislative hearings.
<br/><br/><label>LC Class. No.: </label>KF27  / .O964 2019a 
<br/><br/><label>GPO Item No.: </label>1016-C (online) 
<br/><br/><label>Gov. Doc. Class. No.: </label>Y 4.OV 2:116-08 
<br/><br/><label>Report. No.: </label>Serial no. 116-08 (United States. Congress. House. Committee on Oversight and Reform)